Prospect Financial Services LLC
Position in ACXP — Acurx Pharmaceuticals, Inc.
CIK 2012519
MELVILLE, NY
Position in ACXP
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$21,366
-$29,776 QoQ
Shares Held
13,785
0.0% QoQ
Ownership
0.262%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#5
of 19 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ACXP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Prospect Financial Services LLC holds $21,366 across 1 Biotechnology name. ACXP ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ACXP |
Acurx Pharmaceuticals, Inc.
This page
|
13,785 | $21,366 |
All Filings in ACXP
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,366 | 13,785 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $51,142 | 13,785 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $49,384 | 19,833 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $85,298 | 19,883 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $151,652 | 296,776 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $142,964 | 366,576 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $267,867 | 329,076 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $560,642 | 295,075 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $625,725 | 278,100 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $668,482 | 272,850 | Shares | Sole | 2024-04-22 | |
| 2023-12-31 | $977,224 | 255,150 | Shares | Sole | 2024-02-20 | |
| No filing history on record for this holder in this stock. | ||||||